A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study
This longitudinal real-world study demonstrates the long-term safety of guselkumab in patients with psoriasis who had chronic infections, cancer or heart disease. Stratification by oncological risk provided valuable insights for therapeutic management.
Authors
- Luca Bianchi (ORCID: https://orcid.org/0000-0001-8697-6896)
- Lorenzo Marcelli (ORCID: https://orcid.org/0009-0003-7635-5131)
- Francesco Loconsole (ORCID: https://orcid.org/0000-0003-2852-9451)
- Edoardo Mortato (ORCID: https://orcid.org/0009-0008-3763-6922)
- Maria Esposito (ORCID: https://orcid.org/0000-0002-4773-6993)
- Matteo Megna (ORCID: https://orcid.org/0000-0003-1803-2046)
- Claudio Bonifati (ORCID: https://orcid.org/0000-0001-7752-4337)
- Tommaso Bianchelli (ORCID: https://orcid.org/0000-0003-1323-0158)
- Anna Campanati (ORCID: https://orcid.org/0000-0002-3740-0839)
- Dario Buononato (ORCID: https://orcid.org/0000-0002-6223-5150)
- Nicoletta Bernardini (ORCID: https://orcid.org/0000-0002-6295-3574)
- Annunziata Raimondo (ORCID: https://orcid.org/0000-0002-0849-715X)
- Marina Talamonti (ORCID: https://orcid.org/0000-0002-3070-4071)
- Marco Galluzzo (ORCID: https://orcid.org/0000-0002-3424-5175)
- Nevena Skroza (ORCID: https://orcid.org/0000-0003-4478-5404)
- Anna Balato (ORCID: https://orcid.org/0000-0001-5485-0172)
- Luca Potestio (ORCID: https://orcid.org/0000-0001-5940-0592)
- Maria Concetta Fargnoli (ORCID: https://orcid.org/0000-0002-7249-2556)
- Nello Tommasino (ORCID: https://orcid.org/0009-0002-7997-1784)
- Viviana Lora (ORCID: https://orcid.org/0000-0002-7551-9750)
- Giacomo Caldarola (ORCID: https://orcid.org/0000-0002-8837-9232)
- Clara De Simone (ORCID: https://orcid.org/0000-0002-0898-0045)
- F. Primavera (ORCID: https://orcid.org/0000-0001-6253-8656)
- Eleonora De Luca (ORCID: https://orcid.org/0000-0003-3893-2869)
- Serena Lembo
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Rome Tor Vergata (IT)
- Marche Polytechnic University (IT)
- University of Salerno (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of L'Aquila (IT)
- Agostino Gemelli University Polyclinic (IT)
- Institute of Dermatology (TH)
- Policlinico Tor Vergata (IT)
- San Gallicano Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Bari Aldo Moro (IT)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1093/ced/llaf172
- Citations
- 3
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- Eli Lilly and Company
- Pfizer
- Sanofi